Tenders in Germany

7,611 open tenders available

7601
Dec 31 πŸ”’ Locked

Conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure.

KKH COMMERCIAL HEALTH INSURANCE COMPANY

<br/>The KaufmΓ€nnische Krankenkasse - KKH (hereinafter KKH) pursues the goal of concluding discount agreements with all suitable pharmaceutical companies in acc...

Germany
Deadline: Dec 31, 2026
11 views
Unlock & View β†’
7602
Nov 30 πŸ”’ Locked

Open House Biologics Discount Agreements 2025-25 - Aflibercept (ATC: S01LA05; Potency: 40 mg/ml)

TECHNICIANS' HEALTH INSURANCE

<br/>The TK pursues the goal of concluding discount agreements with all suitable pharmaceutical companies in accordance with Section 130a Paragraph 8 SGB V for ...

Germany
Deadline: Nov 30, 2026
11 views
Unlock & View β†’
7603
Jul 31 πŸ”’ Locked

Open House Biologics Discount Agreements 2026-23 - Darbepoetin alfa

TECHNICIANS' HEALTH INSURANCE

<br/>The TK pursues the goal of concluding discount agreements with all suitable pharmaceutical companies in accordance with Section 130a Paragraph 8 SGB V for ...

Germany
Deadline: Jul 31, 2028
13 views
Unlock & View β†’
7604
Dec 31 πŸ”’ Locked

Conclusion of a non-exclusive framework agreement for planning traffic facilities 2025 ff. in the open house process of the federal Autobahn GmbH (OH-ZEN-2025_01)

THE FEDERAL AUTOBAHN GMBH

<br/>The subject of lot/service area 01 are planning services for simple route maintenance measures (at least pavement renewal) with simple boundary conditions,...

Germany
Deadline: Dec 31, 2026
10 views
Unlock & View β†’
7605
May 5 πŸ”’ Locked

Open framework agreement on drug discounts in accordance with Section 130a Paragraph 8 SGB V with the possibility of joining at any time, so-called approval model 2026-07

GERMAN PENSION INSURANCE KNAPPSCHAFT-BAHN-SEE

<br/>This announcement serves to conclude agreements with pharmaceutical companies within the meaning of Section 130a Paragraph 8 Sentence 1 SGB V. The invitati...

Germany
Deadline: May 5, 2028
9 views
Unlock & View β†’
7606
Closing Today! πŸ”’ Locked

Framework agreement for textile laundry, here the washing, dry cleaning and textile care of federally owned textiles and tablecloths from the accommodation sector in ErndtebrΓΌck

BUNDESWEHR SERVICE CENTER COLOGNE

<br/>Framework agreement for textile laundry, here the washing, dry cleaning and textile care of federally owned textiles and tablecloths from the accommodation...

Germany
Deadline: Aug 19, 2026
12 views
Unlock & View β†’
7607
Mar 31 πŸ”’ Locked

Conclusion not excluding drug discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient oxycodone/naloxone (ATC code according to WHO: N02AA55)

AOK PLUS - THE HEALTH INSURANCE FUND FOR SAXONY AND THURINGIA

<br/>The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for medicines with...

Germany
Deadline: Mar 31, 2027
11 views
Unlock & View β†’
7608
May 31 πŸ”’ Locked

Medicines with the active ingredient filgrastim (ATC: L03AA02)

AOK SAXONY - ANHALT

<br/>The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for finished medic...

Germany
Deadline: May 31, 2028
8 views
Unlock & View β†’
7609
May 31 πŸ”’ Locked

Medicines with the active ingredient teriparatide (ATC: H05AA02)

AOK SAXONY - ANHALT

<br/>The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for finished medic...

Germany
Deadline: May 31, 2028
7 views
Unlock & View β†’
7610
May 31 πŸ”’ Locked

Medicines with the active ingredient denosumab (ATC: M05BX04)

AOK SAXONY - ANHALT

<br/>The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for finished medic...

Germany
Deadline: May 31, 2028
11 views
Unlock & View β†’
7611
May 31 πŸ”’ Locked

Medicines with the active ingredient ustekinumab (ATC: L04AC05)

AOK SAXONY - ANHALT

<br/>The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for finished medic...

Germany
Deadline: May 31, 2028
12 views
Unlock & View β†’